Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, 6 capecitabine, cisplatin ( paxg regimen) in metastatic pancreatic adenocarcinoma

被引：0
|
作者：
Zanon, S. [1 ]
Pircher, C. [1 ]
Chiaravalle, M. [1 ]
Macchini, M. [1 ]
Peretti, U. [1 ]
Balzano, G. [1 ]
Passoni, P. [1 ]
Nicoletti, R. [1 ]
Arcidiacono, P. G. [1 ]
Pepe, G. [1 ]
Doglioni, C. [1 ]
Romi, S. [1 ]
Gritti, E. [1 ]
Falconi, M. [1 ]
Gianni, L. [1 ]
Reni, M. [1 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
D3
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [1] Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (PAXG regimen) in metastatic pancreatic adenocarcinoma
    Reni, M.
    Zanon, S.
    Pircher, C.
    Chiaravalli, M.
    Macchini, M.
    Peretti, U.
    Mazza, E.
    Balzano, G.
    Passoni, P.
    Nicoletti, R.
    Arcidiacono, P. G.
    Pepe, G.
    Doglioni, C.
    Romi, S.
    Ceraulo, D.
    Falconi, M.
    Gianni, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (PAXG regimen) in unresectable or borderline resectable pancreatic adenocarcinoma
    Reni, M.
    Zanon, S.
    Balzano, G.
    Passoni, P.
    Costantino, A.
    Pircher, C.
    Chiaravalli, M.
    Nicoletti, R.
    Arcidiacono, P. G.
    Pepe, G.
    Crippa, S.
    Doglioni, C.
    Fugazza, C.
    Ceraulo, D.
    Falconi, M.
    Gianni, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] A randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in unresectable or borderline resectable pancreatic adenocarcinoma: the ghost regimen strikes back
    Reni, M.
    Zanon, S.
    Balzano, G.
    Passoni, P.
    Costantino, A.
    Pircher, C.
    Chiaravalli, M.
    Nicoletti, R.
    Arcidiacono, P. G.
    Pepe, G.
    Crippa, S.
    Doglioni, C.
    Fugazza, C.
    Ceraulo, D.
    Falconi, M.
    Gianni, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
    Michele Reni
    Gianpaolo Balzano
    Silvia Zanon
    Paolo Passoni
    Roberto Nicoletti
    Paolo Giorgio Arcidiacono
    Gino Pepe
    Claudio Doglioni
    Clara Fugazza
    Domenica Ceraulo
    Massimo Falconi
    Luca Gianni
    British Journal of Cancer, 2016, 115 : 290 - 296
  • [5] Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
    Reni, Michele
    Balzano, Gianpaolo
    Zanon, Silvia
    Passoni, Paolo
    Nicoletti, Roberto
    Arcidiacono, Paolo Giorgio
    Pepe, Gino
    Doglioni, Claudio
    Fugazza, Clara
    Ceraulo, Domenica
    Falconi, Massimo
    Gianni, Luca
    BRITISH JOURNAL OF CANCER, 2016, 115 (03) : 290 - 296
  • [6] Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
    Reni, Michele
    Zanon, Silvia
    Peretti, Umberto
    Chiaravalli, Marta
    Barone, Diletta
    Pircher, Chiara
    Balzano, Gianpaolo
    Macchini, Marina
    Romi, Silvia
    Gritti, Elena
    Mazza, Elena
    Nicoletti, Roberto
    Doglioni, Claudio
    Falconi, Massimo
    Gianni, Luca
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (10): : 691 - 697
  • [7] Phase II trial of capecitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma
    Scheithauer, W.
    Kornek, G.
    Prager, G.
    Stranzl, N.
    Laengle, F.
    Schindl, M.
    Friedl, J.
    Klech, J.
    Roethlin, S.
    Zielinski, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [8] Phase II trial of capecitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma
    Scheithauer, Werner
    Kornek, Gabriela
    Prager, Gerald
    Stranzl, Nadja
    Laengle, Friedrich
    Schindl, Martin
    Friedl, Josef
    Klech, Julia
    Roethlin, Sabine
    Zielinski, Christoph
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (02) : 234 - 238
  • [9] A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
    Andrew H. Ko
    Thach-Giao Truong
    Emily Kantoff
    Kimberly A. Jones
    Elizabeth Dito
    Anna Ong
    Margaret A. Tempero
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 875 - 881
  • [10] A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
    Ko, Andrew H.
    Truong, Thach-Giao
    Kantoff, Emily
    Jones, Kimberly A.
    Dito, Elizabeth
    Ong, Anna
    Tempero, Margaret A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 875 - 881
12345